Cancer Immunotherapy for Gliomas: Overview and Future Directions

Immunotherapy has been highlighted because we have obtained much evidence, which includes theoretical backborn as well as favorable results from clinical trials. As immunotherapy gives an apparently different cytotoxic mechanism and a little adverse event, the promising results are getting a lot of...

Descripción completa

Detalles Bibliográficos
Autor principal: HASHIMOTO, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japan Neurosurgical Society 2016
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945593/
https://www.ncbi.nlm.nih.gov/pubmed/27087194
http://dx.doi.org/10.2176/nmc.ra.2015-0310
_version_ 1782442890785456128
author HASHIMOTO, Naoya
author_facet HASHIMOTO, Naoya
author_sort HASHIMOTO, Naoya
collection PubMed
description Immunotherapy has been highlighted because we have obtained much evidence, which includes theoretical backborn as well as favorable results from clinical trials. As immunotherapy gives an apparently different cytotoxic mechanism and a little adverse event, the promising results are getting a lot of attention. In this article, cancer immunotherapy for gliomas is reviewed thoroughly from the literature, focusing on the clinical trial results.
format Online
Article
Text
id pubmed-4945593
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher The Japan Neurosurgical Society
record_format MEDLINE/PubMed
spelling pubmed-49455932016-07-15 Cancer Immunotherapy for Gliomas: Overview and Future Directions HASHIMOTO, Naoya Neurol Med Chir (Tokyo) Review Article Immunotherapy has been highlighted because we have obtained much evidence, which includes theoretical backborn as well as favorable results from clinical trials. As immunotherapy gives an apparently different cytotoxic mechanism and a little adverse event, the promising results are getting a lot of attention. In this article, cancer immunotherapy for gliomas is reviewed thoroughly from the literature, focusing on the clinical trial results. The Japan Neurosurgical Society 2016-07 2016-04-16 /pmc/articles/PMC4945593/ /pubmed/27087194 http://dx.doi.org/10.2176/nmc.ra.2015-0310 Text en © 2016 The Japan Neurosurgical Society This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/
spellingShingle Review Article
HASHIMOTO, Naoya
Cancer Immunotherapy for Gliomas: Overview and Future Directions
title Cancer Immunotherapy for Gliomas: Overview and Future Directions
title_full Cancer Immunotherapy for Gliomas: Overview and Future Directions
title_fullStr Cancer Immunotherapy for Gliomas: Overview and Future Directions
title_full_unstemmed Cancer Immunotherapy for Gliomas: Overview and Future Directions
title_short Cancer Immunotherapy for Gliomas: Overview and Future Directions
title_sort cancer immunotherapy for gliomas: overview and future directions
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4945593/
https://www.ncbi.nlm.nih.gov/pubmed/27087194
http://dx.doi.org/10.2176/nmc.ra.2015-0310
work_keys_str_mv AT hashimotonaoya cancerimmunotherapyforgliomasoverviewandfuturedirections

Ejemplares similares